Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 107
- Press releases
5th Birthday of Medical Cannabis Awareness Week Approaches
The fifth anniversary of Medical Cannabis Awareness Week (#MCAW) is set for 1 – 7 November 2023.
- Uncategorized
Number of Georgia Medical Cannabis Patients Less Than Half Previously Reported
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
New Jersey Makes $5.5m in Cannabis Revenues Available To Help Victims of Violent Crime
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
Chair of Massachusetts Cannabis Regulator Calls Suspension ‘Unlawful’ as She Launches Legal Challenge
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- CBD Market
Hempura: CBD Products Pioneers Join the BRITISH CANNABIS™ Family
Hempura, a leading CBD brand, has recently been acquired by new parent company, BRITISH CANNABIS™.
- Uncategorized
Aurora Signs C$38.8m Deal To Pay Down Debt
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Medical
Medical Cannabis in France Faces Uncertain Future Amid Government Inaction
The future of France’s medical cannabis programme has been thrown into doubt this week as the government failed to introduce any sort of regulatory framework or allocate any funding in its annual budget.
- Press releases
Australian Success Story Alternaleaf Launches in the UK; On the Quest to Make Medical Cannabis More Accessible
Alternaleaf, the clinic that’s helped hundreds of thousands of Australians access medical cannabis, today is launching in the UK.
- Uncategorized
British Columbia Allows Producers To Promote Products By Offering Samples
Cannabis producers with a federal licence in British Columbia will now be able to promote their products by offering samples to retailers for a ‘nominal fee’.
- Markets & Stocks
MGC Pharma In ‘Critical Financial Juncture’ As It Launches Restructuring Plan, Europes First Cannabis ETF To Be Merged As ‘No Longer Viable’, & More From Akanda
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in 2021, informed investors this week that due to adverse market conditions it ‘finds itself at a critical financial juncture’.
- Companies
OCT Emerges Strong from a Pivotal Year, Nears Release of Milestone Clinical Trial Results
This week, British pharmaceutical cannabis firm Oxford Cannabinoid Technologies (OCT) announced that the ‘final dose’ in its crucial Phase I clinical trial had been administered, with no ‘drug adverse effects observed’.
- Companies
BRITISH CANNABIS™ Acquires PhytoVista Laboratories: A Standard-Bearer in Cannabinoid Testing & Compliance
BRITISH CANNABIS™ is pleased to announce the strategic acquisition and continued operation of PhytoVista Laboratories (a UKAS accredited testing laboratory No. 20213) under one roof., the only cannabinoid specialist lab in the UK to combine Home Office licenses for THC testing, and UKAS accreditation.











